ArticleMolecular medicine (Cambridge, Mass.)2023

RILP inhibits tumor progression in osteosarcoma via Grb10-mediated inhibition of the PI3K/AKT/mTOR pathway.

Zhun Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.